|
Bill Smith is Managing Director of NSI’s Healthcare practice group. Marc Kealey is Chief Advocate, Kealey & Associates Inc. They say why American and Canadian family caregivers and their families should be interested in drug reform. They explain what’s meant by ‘generic’ and ‘brand-name’ drugs and discuss their differences in costs and medically. They explain how drug plans work in the US and Canada, identify any important gaps, and say what they think needs doing to close the gaps. They discuss planners and politicians’ concerns about ever-rising costs of drugs and drug plans. They say how th
|
